Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy

TerminatedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Progressive Multifocal Leukoencephalopathy
Trial Locations (11)

10003

NYU Hospital for Joint Disease, MS Care Center, New York

14642

University of Rochester, Rochester

35058

North Central Neurology Associates, Cullman

45208

Research Site, Cincinnati

46260

St. Vincent Hospital, St. Vincent Neuroscience Institute, Indianapolis

60612

Rush Medical Center - Rush Multiple Sclerosis Center, Chicago

68105

Clinical Research Center UH, The Nebraska Medical Center, Omaha

68901

Central Neurology, Hastings

80045

Rocky Mountain MS Center at Anschutz Medical Campus University Colorado Denver, Aurora

97701

Neurology of Bend, LLC, Bend

Unknown

Research Site, Würzburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY